Beyond Air Enters Definitive Agreement With UNIVO For NeuroNOS Stake; Stock Down

Beyond Air (NASDAQ: XAIR) signed a definitive agreement to sell its majority stake in NeuroNOS Israel Ltd. to UNIVO Pharmaceutical Industries (UNVO) for consideration consisting of equity and milestone payments. The transaction suggests a strategic repositioning/portfolio monetization, but specific $/timing terms and milestone amounts were not provided in the article. Overall read-through is mildly positive given the definitive nature of the deal.